Description
Regadenoson is an adenosine A2A receptor agonist that displays vasodilatory activity. Regadenoson is clinically used in myocardial perfusion imaging.
Regadenoson
Product ID R1724
Cas No. 313348-27-5
Purity ≥99%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Cas No. | 313348-27-5 |
|---|---|
| Purity | ≥99% |
| Formula | C15H18N8O5 |
| Formula Wt. | 390.35 |
| IUPAC Name | 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide |
| Solubility | Soluble in DMSO, and methanol |
| Appearance | White to off white powder |
Shipping and Storage
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
Palani G, Ananthasubramaniam K. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications. Cardiol Rev. 2013 Jan-Feb;21(1):42-8. PMID: 22643345.
Cerqueira MD. The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol. 2004 Jul 22;94(2A):33D-40D; discussion 40D-42D. PMID: 15261132.